Brind.

AbbVie and ICF International were analyzed as value stocks in a comparison of value investing strategies.

1 report, 1 independent Updated Jul 28

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

AbbVie ICF International

Keep exploring

The entities involved

AbbVie
pharmaceutical company
- MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
- AbbVie's product portfolio was bolstered by the acquisition of Allergan, while Humira sales faced erosion due to patent loss and biosimilar competition.Sun 13:48
ICF International
American consulting firm

Nothing else this week.

Coverage

Newest first; wire copies grouped

Jul 28StockStory3 Value Stocks with Questionable Fundamentals Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at r